Abstract
The objective of this study was to investigate the transport kinetics of cyclosporin A, a well known substrate for P-glycoprotein (P-gp), across the blood-brain barrier (BBB), and the expression of the transporter in the brain of streptozotocin-induced diabetic rats. The in vivo transport clearance of cyclosporin A was significantly reduced in diabetic rats compared with that in the control. The decreased transport was associated with the increased level of mRNA and the protein for P-glycoprotein in the rat brain. The functional activity of the efflux transporter in mouse brain capillary endothelial (MBEC4) cells, an in vitro model of the BBB, was also stimulated when slow nitric oxide (NO)-releasing donors were present, whereas the stimulation was absent in the case of rapid NO-releasing donors (e.g., S-nitroso-N-acetyl-dl-penicillamine and diethylenetriamine). The stimulatory effect was highest for sodium nitroprusside (SNP) and the functional induction associated with the increased mRNA and protein level of the transporter. The pretreatment of the cell with SNP along with ascorbate, methylene blue, or superoxide dismutase attenuated the induction of function and expression for P-glycoprotein, suggesting that the reaction product between superoxide and NO is involved in the induction of function and expression. The level of nuclear translocation of nuclear factor-κB (NF-κB) and DNA binding activity of nuclear extracts to the NF-κB consensus oligonucleotide was increased in MBEC4 cells pretreated with SNP. Taken together, these observations suggest that nitrosative stress leads to the up-regulation of the message for the efflux transporter and, ultimately, to the enhanced function, probably via a NF-κB-dependent mechanism.
Footnotes
-
This study was supported by a grant (A03-0001-A71005-06M4-13010A) from the Ministry of Health & Welfare, Republic of Korea, and a grant from the health fellowship foundation.
-
doi:10.1124/dmd.107.015800.
-
ABBREVIATIONS: NOx, nitrogen oxide(s); NO, nitric oxide; STZ, streptozotocin; SNP, sodium nitroprusside; SIN-1, 3-morpholinosydnonimine; SNAP, S-nitroso-N-acetyl-dl-penicillamine; DETA, diethylenetriamine; MBEC4, mouse brain capillary endothelial; BBB, blood-brain barrier; RT-PCR, reverse transcription-polymerase chain reaction; Mdr, multidrug resistance; Mrp, multidrug resistance protein; ABC, ATP-binding cassette; NF-κB, nuclear factor-κB; CsA, cyclosporin A; SOD, superoxide dismutase; ANOVA, analysis of variance; CL, clearance; CLapp,br, apparent brain clearance; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
- Received March 21, 2007.
- Accepted July 25, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|